Sandoz Canada lance (Pr)Sandoz Levetiracetam® en comprimés de 1 000 mg pour le traitement adjuvant de l’épilepsie
07. Juni 2018 07:00 ET
|
Sandoz Canada
Sandoz Canada est la première entreprise au Canada à offrir le lévétiracétam dans une concentration de 1 000 mg, ce qui permet aux patients de réduire le nombre de comprimés à prendre...
Sandoz Canada launches (Pr)Sandoz Levetiracetam® 1000 mg tablets as an adjunctive treatment of epilepsy
07. Juni 2018 07:00 ET
|
Sandoz Canada
Sandoz Canada is the first company in Canada to offer levetiracetam in the higher concentration 1000 mg, enabling patients to reduce the number of tablets they need to take daily.PrSandoz...
Sandoz Canada launches PrSandoz(R) Duloxetine, a generic version of Cymbalta*, for the treatment of depression and anxiety symptoms
17. Mai 2016 14:42 ET
|
Sandoz Canada
Click on this link to read the French version
BOUCHERVILLE, QC, May 17, 2016 (GLOBE NEWSWIRE) -- Sandoz Canada announced today that it has launched on the Canadian market PrSandoz®...
Sandoz Canada Inc. launches PrTOBRAMYCIN INHALATION SOLUTION, a generic version of PrTOBI indicated for pulmonary infections in cystic fibrosis patients
31. März 2016 09:19 ET
|
Sandoz Canada
BOUCHERVILLE, QC, March 31, 2016 (GLOBE NEWSWIRE) -- Sandoz Canada Inc. announced the launch of PrTOBRAMYCIN INHALATION SOLUTION, an authorized generic version of PrTOBI*, currently marketed by...
Sandoz Canada launches two easy-to-use products: Salinex(R) Seawater nasal spray for daily care and Ezeva(TM) zinc oxide cream
07. Dezember 2015 12:51 ET
|
Sandoz Canada
Lire la version française
BOUCHERVILLE, Quebec, Dec. 7, 2015 (GLOBE NEWSWIRE) -- Sandoz Canada announced today the launch of two easy-to-use products: Salinex® Seawater to help reduce...
Sandoz Canada Launches a New Concentration of (T/C)Lorazepam Injection USP
02. Dezember 2015 19:54 ET
|
Sandoz Canada
Lire la version française
BOUCHERVILLE, Quebec, Dec. 2, 2015 (GLOBE NEWSWIRE) -- Sandoz Canada is pleased to announce the launch of (T/C)Lorazepam Injection USP 2 mg/mL, a new concentration...
Sandoz Canada Launches a New Concentration of T/CLorazepam Injection USP
02. Dezember 2015 14:19 ET
|
Sandoz Canada
Lire la version française
BOUCHERVILLE, Quebec, Dec. 2, 2015 (GLOBE NEWSWIRE) -- Sandoz Canada is pleased to announce the launch of T/CLorazepam Injection USP 2 mg/mL, a new concentration now...
Sandoz Canada launches new multi-platform application to show real-time availability of its injectable medicines
14. Oktober 2015 13:28 ET
|
Sandoz Canada
Version française
BOUCHERVILLE, Quebec, Oct. 14, 2015 (GLOBE NEWSWIRE) -- Sandoz Canada, which established a milestone in transparency by providing the first national report on availability...
Sandoz Canada launches PrSandoz(R) Solifenacin on the Canadian market for the treatment of urinary urgency, frequency and incontinence
07. Oktober 2015 16:41 ET
|
Sandoz Canada
Version française
BOUCHERVILLE, QC, Oct. 7, 2015 (GLOBE NEWSWIRE) -- Sandoz Canada announced today the launch of a new drug on the Canadian market, PrSandoz® Solifenacin (solifenacin...
Sandoz Canada Celebrates Its 10th Anniversary!
25. September 2015 09:15 ET
|
Sandoz Canada
Lire la version française
BOUCHERVILLE, Quebec, Sept. 25, 2015 (GLOBE NEWSWIRE) -- Sandoz Canada Inc. celebrated its 10th anniversary on September 19 this year with a colourful event in...